PTL is a world-leading innovator in the fields of recombinant proteins, protein engineering, biotherapeutics, biosensors, and bioreactors, and has received multiple awards and funding from organizations such as the UK government’s Technology Strategy Board, Bill and Melinda Gates Foundation, and The Wellcome Trust. The company operates from state-of-the-art laboratories at Manchester Science Park in the United Kingdom and offers professional, cost-effective contract research services to the highest standards of customer satisfaction.